Broad spectrum inhibition of HIV-1 infection by sulfated K5 Escherichia coli polysaccharide derivatives
- 1 January 2003
- journal article
- Published by Wolters Kluwer Health in AIDS
- Vol. 17 (2) , 177-181
- https://doi.org/10.1097/00002030-200301240-00006
Abstract
HIV-1 entry into CD4 cells represents a main target for developing novel antiretroviral agents and microbicides. Sulfated derivatives of the K5 polysaccharide have a backbone structure resembling the heparin precursor, but are devoid of the anticoagulant activity. The derivatives were chemically sulfated in the N position after N-deacetylation, in the O position, or in both sites. HIV replication in human T cell blasts, monocyte-derived macrophages and cell lines was studied in the presence of sulfated K5 derivatives. O-sulfated [K5-OS(H)] and N,O-sulfated [K5-N,OS(H)] K5 derivatives with high degree of sulfation inhibited the replication of an HIV strain using CXCR4 as entry co-receptor (X4 virus) in both cell lines and T-cell blasts. K5 derivatives also strongly inhibited the multiplication of CCR5-dependent HIV (R5 virus) in cell lines, T-cell blasts and primary monocyte-derived macrophages. Their 50% inhibitory concentration was between 0.07 and 0.46 microM, without evidence of cytotoxicity even at the maximal concentration tested (9 microM). In addition, both K5-N,OS(H) and K5-OS(H) potently inhibited the replication of several primary HIV-1 isolates in T-cell blasts, with K5-N,OS(H) being more active than K5-OS(H) on dual tropic R5X4 strains. K5 derivatives inhibited the early steps of virion attachment and/or entry. Because K5 derivatives are unlikely to penetrate into cells they may represent potential topical microbicides for the prevention of sexual HIV-1 transmission.Keywords
This publication has 31 references indexed in Scilit:
- Fibroblast Growth Factor-2 Antagonist Activity and Angiostatic Capacity of Sulfated Escherichia coli K5 Polysaccharide DerivativesJournal of Biological Chemistry, 2001
- Syndecans Serve as Attachment Receptors for Human Immunodeficiency Virus Type 1 on MacrophagesJournal of Virology, 2001
- Inhibition of R5X4 Dualtropic HIV-1 Primary Isolates by Single Chemokine Co-receptor LigandsVirology, 2001
- New targets for inhibitors of HIV-1 replicationNature Reviews Molecular Cell Biology, 2000
- Host cyclophilin A mediates HIV-1 attachment to target cells via heparansThe EMBO Journal, 1999
- Heparin and its derivatives bind to HIV-1 recombinant envelope glycoproteins, rather than to recombinant HIV-1 receptor, CD4Glycobiology, 1998
- Sulfated Polysaccharides Extracted from Sea Algae as Potential Antiviral DrugsGeneral Pharmacology: The Vascular System, 1997
- Anti-HIV-1 Activity of Chemically Modified Heparins: Correlation between Binding to the V3 Loop of gp120 and Inhibition of Cellular HIV-1 Infection in vitroBiochemistry, 1994
- Heparin specifically inhibits binding of V3 loop antibodies to HIV-1 gp120, an effect potentiated by CD4 bindingAIDS, 1994
- The Structure of the Capsular Polysaccharide (K5 Antigenn) of Urinary-Tract-Infective Escherichia coli 010:K5:H4. A Polymer Similar to Desulfo-HeparinEuropean Journal of Biochemistry, 1981